Terms: = Head and neck cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC AND Treatment
17 results:
1. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
Ferreira AMC; Altemani JMC; Macedo LT; Lourenço GJ; Lima CSP
Sci Rep; 2023 Oct; 13(1):16762. PubMed ID: 37798436
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
Panje C; Hayoz S; Eisterer W; Hess V; Thuss-Patience P; Schacher S; Dürr D; Wagner AD; Girschikofsky M; Eboulet E; Stahl M; Ruhstaller T
Eur J Cancer; 2022 Dec; 177():186-193. PubMed ID: 36368252
[TBL] [Abstract] [Full Text] [Related]
3. The DNA damage response network in the treatment of head and neck squamous cell carcinoma.
Psyrri A; Gkotzamanidou M; Papaxoinis G; Krikoni L; Economopoulou P; Kotsantis I; Anastasiou M; Souliotis VL
ESMO Open; 2021 Apr; 6(2):100075. PubMed ID: 33714009
[TBL] [Abstract] [Full Text] [Related]
4. Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal cancer: An Intergroup Phase III Trial of the Swiss Group for Clinical cancer Research (SAKK 75/08).
von Holzen U; Schmidt S; Hayoz S; Steffen T; Grieder F; Bartsch D; Schnider A; Knoefel WT; Piessen G; Kettelhack C; Marti WR; Schäfer M; Függer R; Köigsrainer A; Gloor B; Furrer M; Gérard MA; Hawle H; Walz MK; Alesina P; Ruhstaller T;
Ann Surg; 2022 Jun; 275(6):1130-1136. PubMed ID: 33055589
[TBL] [Abstract] [Full Text] [Related]
5. High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.
Fehr M; Hawle H; Hayoz S; Thuss-Patience P; Schacher S; Riera Knorrenschild J; Dürr D; Knoefel WT; Rumpold H; Bitzer M; Zweifel M; Samaras P; Mey U; Küng M; Winterhalder R; Eisterer W; Hess V; Gérard MA; Templeton A; Stahl M; Ruhstaller T; ; ; ;
BMC Cancer; 2020 Feb; 20(1):166. PubMed ID: 32111181
[TBL] [Abstract] [Full Text] [Related]
6. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract] [Full Text] [Related]
7. Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).
Ruhstaller T; Thuss-Patience P; Hayoz S; Schacher S; Knorrenschild JR; Schnider A; Plasswilm L; Budach W; Eisterer W; Hawle H; Mariette C; Hess V; Mingrone W; Montemurro M; Girschikofsky M; Schmidt SC; Bitzer M; Bedenne L; Brauchli P; Stahl M; ; ; ;
Ann Oncol; 2018 Jun; 29(6):1386-1393. PubMed ID: 29635438
[TBL] [Abstract] [Full Text] [Related]
8. GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in head and neck cancer Patients treated with Cisplatin Chemoradiation.
Carron J; Lopes-Aguiar L; Costa EFD; Nogueira GAS; Lima TRP; Pincinato EC; Visacri MB; Quintanilha JCF; Moriel P; Lourenço GJ; Lima CSP
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):520-525. PubMed ID: 28686330
[TBL] [Abstract] [Full Text] [Related]
9. Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy.
Zhou F; Zhu M; Wang M; Qiu L; Cheng L; Jia M; Xiang J; Wei Q
J Transl Med; 2016 May; 14(1):154. PubMed ID: 27246611
[TBL] [Abstract] [Full Text] [Related]
10. Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer.
Gusella M; Giacopuzzi S; Bertolaso L; Zanoni A; Pezzolo E; Modena Y; Menon D; Paganin P; Weindelmayer J; Crepaldi G; De Manzoni G; Pasini F
Pharmacogenomics J; 2017 Jun; 17(3):252-257. PubMed ID: 26927287
[TBL] [Abstract] [Full Text] [Related]
11. DNA repair genes xpc, XPD, XRCC1, and XRCC3 are associated with risk and survival of squamous cell carcinoma of the head and neck.
Farnebo L; Stjernström A; Fredrikson M; Ansell A; Garvin S; Thunell LK
DNA Repair (Amst); 2015 Jul; 31():64-72. PubMed ID: 26001739
[TBL] [Abstract] [Full Text] [Related]
12. DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.
Zhou Q; Zou BW; Xu Y; Xue JX; Meng MB; Liu FJ; Deng L; Ma DY; Ao R; Lu Y
Tumour Biol; 2015 Mar; 36(3):1539-48. PubMed ID: 25374063
[TBL] [Abstract] [Full Text] [Related]
13. Single nucleotide polymorphisms in nucleotide excision repair genes, cancer treatment, and head and neck cancer survival.
Wyss AB; Weissler MC; Avery CL; Herring AH; Bensen JT; Barnholtz-Sloan JS; Funkhouser WK; Olshan AF
Cancer Causes Control; 2014 Apr; 25(4):437-50. PubMed ID: 24487794
[TBL] [Abstract] [Full Text] [Related]
14. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
[TBL] [Abstract] [Full Text] [Related]
15. The survival impact of XPA and xpc genetic polymorphisms on patients with esophageal squamous cell carcinoma.
Yang PW; Hsieh CY; Kuo FT; Huang PM; Hsu HH; Kuo SW; Chen JS; Lee JM
Ann Surg Oncol; 2013 Feb; 20(2):562-71. PubMed ID: 22941172
[TBL] [Abstract] [Full Text] [Related]
16. Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.
Liu RY; Dong Z; Liu J; Yin JY; Zhou L; Wu X; Yang Y; Mo W; Huang W; Khoo SK; Chen J; Petillo D; Teh BT; Qian CN; Zhang JT
Oncogene; 2011 Dec; 30(48):4814-23. PubMed ID: 21625209
[TBL] [Abstract] [Full Text] [Related]
17. treatment of eyelid epithelial neoplasm by targeting sonic hedgehog signaling: an experimental study.
Miyazaki KI; Saika S; Yamanaka O; Okada Y; Ohnishi Y
Jpn J Ophthalmol; 2006; 50(4):305-311. PubMed ID: 16897213
[TBL] [Abstract] [Full Text] [Related]
